Poliomyelitis Vaccines Market - Global Outlook and Forecast 2022-2028

March 2022 | 78 pages | ID: P36A6E9877DAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Poliomyelitis Vaccines in global, including the following market information:

Global Poliomyelitis Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Poliomyelitis Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Poliomyelitis Vaccines companies in 2021 (%)

The global Poliomyelitis Vaccines market was valued at 730.3 million in 2021 and is projected to reach US$ 957.4 million by 2028, at a CAGR of 3.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

IPV Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Poliomyelitis Vaccines include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poliomyelitis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Poliomyelitis Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccines Market Segment Percentages, by Type, 2021 (%)

• IPV
• OPV

Global Poliomyelitis Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccines Market Segment Percentages, by Application, 2021 (%)

• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Global Poliomyelitis Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Poliomyelitis Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Poliomyelitis Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Poliomyelitis Vaccines revenues share in global market, 2021 (%)

Key companies Poliomyelitis Vaccines sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Poliomyelitis Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• GSK
• Bibcol
• Serum Institute
• Tiantan Biological
• IMBCA
• Panacea Biotec Ltd
• Bio-Med
• Halfkin Bio-Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Poliomyelitis Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Poliomyelitis Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL POLIOMYELITIS VACCINES OVERALL MARKET SIZE

2.1 Global Poliomyelitis Vaccines Market Size: 2021 VS 2028
2.2 Global Poliomyelitis Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Poliomyelitis Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Poliomyelitis Vaccines Players in Global Market
3.2 Top Global Poliomyelitis Vaccines Companies Ranked by Revenue
3.3 Global Poliomyelitis Vaccines Revenue by Companies
3.4 Global Poliomyelitis Vaccines Sales by Companies
3.5 Global Poliomyelitis Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Poliomyelitis Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Poliomyelitis Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliomyelitis Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Poliomyelitis Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Poliomyelitis Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Poliomyelitis Vaccines Market Size Markets, 2021 & 2028
  4.1.2 IPV
  4.1.3 OPV
4.2 By Type - Global Poliomyelitis Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Poliomyelitis Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global Poliomyelitis Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Poliomyelitis Vaccines Sales & Forecasts
  4.3.1 By Type - Global Poliomyelitis Vaccines Sales, 2017-2022
  4.3.2 By Type - Global Poliomyelitis Vaccines Sales, 2023-2028
  4.3.3 By Type - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Poliomyelitis Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Poliomyelitis Vaccines Market Size, 2021 & 2028
  5.1.2 Research & Academic Laboratories
  5.1.3 Pharmaceutical & Biotechnology Companies
  5.1.4 Others
5.2 By Application - Global Poliomyelitis Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Poliomyelitis Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global Poliomyelitis Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Poliomyelitis Vaccines Sales & Forecasts
  5.3.1 By Application - Global Poliomyelitis Vaccines Sales, 2017-2022
  5.3.2 By Application - Global Poliomyelitis Vaccines Sales, 2023-2028
  5.3.3 By Application - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Poliomyelitis Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Poliomyelitis Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Poliomyelitis Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Poliomyelitis Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global Poliomyelitis Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Poliomyelitis Vaccines Sales & Forecasts
  6.3.1 By Region - Global Poliomyelitis Vaccines Sales, 2017-2022
  6.3.2 By Region - Global Poliomyelitis Vaccines Sales, 2023-2028
  6.3.3 By Region - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Poliomyelitis Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America Poliomyelitis Vaccines Sales, 2017-2028
  6.4.3 US Poliomyelitis Vaccines Market Size, 2017-2028
  6.4.4 Canada Poliomyelitis Vaccines Market Size, 2017-2028
  6.4.5 Mexico Poliomyelitis Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Poliomyelitis Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe Poliomyelitis Vaccines Sales, 2017-2028
  6.5.3 Germany Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.4 France Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.5 U.K. Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.6 Italy Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.7 Russia Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries Poliomyelitis Vaccines Market Size, 2017-2028
  6.5.9 Benelux Poliomyelitis Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Poliomyelitis Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia Poliomyelitis Vaccines Sales, 2017-2028
  6.6.3 China Poliomyelitis Vaccines Market Size, 2017-2028
  6.6.4 Japan Poliomyelitis Vaccines Market Size, 2017-2028
  6.6.5 South Korea Poliomyelitis Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia Poliomyelitis Vaccines Market Size, 2017-2028
  6.6.7 India Poliomyelitis Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Poliomyelitis Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America Poliomyelitis Vaccines Sales, 2017-2028
  6.7.3 Brazil Poliomyelitis Vaccines Market Size, 2017-2028
  6.7.4 Argentina Poliomyelitis Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Poliomyelitis Vaccines Sales, 2017-2028
  6.8.3 Turkey Poliomyelitis Vaccines Market Size, 2017-2028
  6.8.4 Israel Poliomyelitis Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia Poliomyelitis Vaccines Market Size, 2017-2028
  6.8.6 UAE Poliomyelitis Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Poliomyelitis Vaccines Major Product Offerings
  7.1.4 Sanofi Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Poliomyelitis Vaccines Major Product Offerings
  7.2.4 GSK Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 GSK Key News
7.3 Bibcol
  7.3.1 Bibcol Corporate Summary
  7.3.2 Bibcol Business Overview
  7.3.3 Bibcol Poliomyelitis Vaccines Major Product Offerings
  7.3.4 Bibcol Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 Bibcol Key News
7.4 Serum Institute
  7.4.1 Serum Institute Corporate Summary
  7.4.2 Serum Institute Business Overview
  7.4.3 Serum Institute Poliomyelitis Vaccines Major Product Offerings
  7.4.4 Serum Institute Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 Serum Institute Key News
7.5 Tiantan Biological
  7.5.1 Tiantan Biological Corporate Summary
  7.5.2 Tiantan Biological Business Overview
  7.5.3 Tiantan Biological Poliomyelitis Vaccines Major Product Offerings
  7.5.4 Tiantan Biological Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Tiantan Biological Key News
7.6 IMBCA
  7.6.1 IMBCA Corporate Summary
  7.6.2 IMBCA Business Overview
  7.6.3 IMBCA Poliomyelitis Vaccines Major Product Offerings
  7.6.4 IMBCA Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.6.5 IMBCA Key News
7.7 Panacea Biotec Ltd
  7.7.1 Panacea Biotec Ltd Corporate Summary
  7.7.2 Panacea Biotec Ltd Business Overview
  7.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Major Product Offerings
  7.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.7.5 Panacea Biotec Ltd Key News
7.8 Bio-Med
  7.8.1 Bio-Med Corporate Summary
  7.8.2 Bio-Med Business Overview
  7.8.3 Bio-Med Poliomyelitis Vaccines Major Product Offerings
  7.8.4 Bio-Med Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.8.5 Bio-Med Key News
7.9 Halfkin Bio-Pharmaceuticals
  7.9.1 Halfkin Bio-Pharmaceuticals Corporate Summary
  7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
  7.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Major Product Offerings
  7.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales and Revenue in Global (2017-2022)
  7.9.5 Halfkin Bio-Pharmaceuticals Key News

8 GLOBAL POLIOMYELITIS VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Poliomyelitis Vaccines Production Capacity, 2017-2028
8.2 Poliomyelitis Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Poliomyelitis Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 POLIOMYELITIS VACCINES SUPPLY CHAIN ANALYSIS

10.1 Poliomyelitis Vaccines Industry Value Chain
10.2 Poliomyelitis Vaccines Upstream Market
10.3 Poliomyelitis Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Poliomyelitis Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Poliomyelitis Vaccines in Global Market
Table 2. Top Poliomyelitis Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Poliomyelitis Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Poliomyelitis Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Poliomyelitis Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Poliomyelitis Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Poliomyelitis Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Poliomyelitis Vaccines Product Type
Table 9. List of Global Tier 1 Poliomyelitis Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poliomyelitis Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Poliomyelitis Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Poliomyelitis Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Poliomyelitis Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Poliomyelitis Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Poliomyelitis Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Poliomyelitis Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Poliomyelitis Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Poliomyelitis Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Poliomyelitis Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Poliomyelitis Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Poliomyelitis Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Poliomyelitis Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Poliomyelitis Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Poliomyelitis Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Poliomyelitis Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Poliomyelitis Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Poliomyelitis Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Poliomyelitis Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Poliomyelitis Vaccines Sales, (K Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Poliomyelitis Vaccines Product Offerings
Table 48. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Poliomyelitis Vaccines Product Offerings
Table 51. GSK Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Bibcol Corporate Summary
Table 53. Bibcol Poliomyelitis Vaccines Product Offerings
Table 54. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Serum Institute Corporate Summary
Table 56. Serum Institute Poliomyelitis Vaccines Product Offerings
Table 57. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Tiantan Biological Corporate Summary
Table 59. Tiantan Biological Poliomyelitis Vaccines Product Offerings
Table 60. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. IMBCA Corporate Summary
Table 62. IMBCA Poliomyelitis Vaccines Product Offerings
Table 63. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Panacea Biotec Ltd Corporate Summary
Table 65. Panacea Biotec Ltd Poliomyelitis Vaccines Product Offerings
Table 66. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bio-Med Corporate Summary
Table 68. Bio-Med Poliomyelitis Vaccines Product Offerings
Table 69. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Halfkin Bio-Pharmaceuticals Corporate Summary
Table 71. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Offerings
Table 72. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Poliomyelitis Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Poliomyelitis Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Poliomyelitis Vaccines Production by Region, 2017-2022 (K Units)
Table 76. Global Poliomyelitis Vaccines Production by Region, 2023-2028 (K Units)
Table 77. Poliomyelitis Vaccines Market Opportunities & Trends in Global Market
Table 78. Poliomyelitis Vaccines Market Drivers in Global Market
Table 79. Poliomyelitis Vaccines Market Restraints in Global Market
Table 80. Poliomyelitis Vaccines Raw Materials
Table 81. Poliomyelitis Vaccines Raw Materials Suppliers in Global Market
Table 82. Typical Poliomyelitis Vaccines Downstream
Table 83. Poliomyelitis Vaccines Downstream Clients in Global Market
Table 84. Poliomyelitis Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Poliomyelitis Vaccines Segment by Type
Figure 2. Poliomyelitis Vaccines Segment by Application
Figure 3. Global Poliomyelitis Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Poliomyelitis Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Poliomyelitis Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Poliomyelitis Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliomyelitis Vaccines Revenue in 2021
Figure 9. By Type - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Poliomyelitis Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Poliomyelitis Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 19. US Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 33. China Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Poliomyelitis Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Poliomyelitis Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Poliomyelitis Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Poliomyelitis Vaccines by Region, 2021 VS 2028
Figure 50. Poliomyelitis Vaccines Industry Value Chain
Figure 51. Marketing Channels